申请人:King Pharmaceuticals Research and Development Inc.
公开号:EP1401441A2
公开(公告)日:2004-03-31
US6727258B2
申请人:——
公开号:US6727258B2
公开(公告)日:2004-04-27
US7112607B2
申请人:——
公开号:US7112607B2
公开(公告)日:2006-09-26
[EN] ALLOSTERIC ADENOSINE RECEPTOR MODULATORS<br/>[FR] MODULATEURS ALLOSTERIQUES DES RECEPTEURS DE L'ADENOSINE
申请人:KING PHARMACEUTICALS RES & DEV
公开号:WO2002074056A2
公开(公告)日:2002-09-26
The present invention relates to compounds of formulas (IA) and (IB): the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric adenosine receptor modulators for uses including protection against hypoxia and ischemia induced injury and treatment of adenosine-sensitive cardiac arrhythmias.